Introducing Christie CounterAct commercial UVC disinfection products
The world needs technology to help return to the places they love. Christie® CounterAct™ commercial UVC disinfection products with patented Care222® technology are designed to continually and effectively neutralize pathogens around people, like the coronavirus that causes COVID-19. CounterAct products are now in production after receiving certification by both UL and CE, organizations that thoroughly test for stringent health, safety, environmental, and photobiological requirements for consumer safety.
And our legacy of light continues as we create industry-leading, award-winning audio visual products, such as our recently reimagined projection workhorse, the M 4K Series and our growing lineup of Real|Laser™ cinema projectors.
Explore our full range of products.